FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use

Early Sleep Improvement and Response to Pharmacotherapy in Psychotic Depression

Orexin: The New Kid on the Insomnia Block

Appropriate Use of Stimulant Medications in Adults With ADHD

Lag in Antidepressant Treatment Response Explained?

GLP-1 Agonists and Suicide Risk: What Action Should Be Taken?

Esketamine Bests Quetiapine for Severe Depression in Head-to-Head Trial

Ketamine No Better for Depression Than Placebo?

FDA Clears First OTC Fentanyl Urine Test

Looking for a Psychiatrist that takes your Insurance?

Confirmed: Intermittent Use of Benzodiazepines Is the Safest Option

Study Finds Esketamine Nasal Spray More Likely to Induce Remission in Treatment-Resistant MDD Than Q

The Making of Adult ADHD: The Rapid Rise of a Novel Psychiatric Diagnosis

Providing Hope During National Suicide Prevention Month

Fentanyl Laced Stimulants Fuel Opioid Crisis' Fourth Wave

Gabapentin May Not Reduce Opioid Use in Chronic Opioid Users

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

“Talk. They Hear You.” Celebrates 10 Years of Preventing Underage Substance Use

Study Says Casual Pot Use Harmful to Teens

Are Ketogenic Supplements the Key to Healthy Aging?